These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6120901)

  • 21. Metabolic fate of carteolol hydrochloride, (OPC-1085) VIII, a new beta-adrenergic blocking agent. Pharmacokinetic studies of carteolol in man.
    Morita S; Iinuma M; Kido M; Sakuragi S; Kohri H; Nishino H
    Arzneimittelforschung; 1977; 27(12):2380-3. PubMed ID: 23800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of metabolites in the relationship between pharmacokinetics and the effect of beta blockers. Studies on tolamolol and bufuralol].
    Tschopp JM; Gorgia A; Balant L; Revillard C; Francis RJ; Fabre FJ
    Schweiz Med Wochenschr; 1978 May; 108(20):756-64. PubMed ID: 26114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-blocking drug metipranolol: plasma levels and pharmacodynamic action in man.
    Mayer O; Cepelák V; Vitous J; Potmĕsil J
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):113-9. PubMed ID: 6103879
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics and urinary excretion of eprosartan in Chinese healthy volunteers of different gender.
    Xu HR; Chen WL; Li XN; Liu GY; Chu NN; Yu C
    Pharmazie; 2007 Oct; 62(10):782-4. PubMed ID: 18236785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamic studies in man of the beta-adrenoceptor antagonist DL 071 IT.
    Radice M; Amanzio R; Criscuolo D
    Eur J Clin Pharmacol; 1979 Sep; 16(2):87-90. PubMed ID: 40801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics of two beta blocking drugs: detection of a pharmacogenetic abnormality].
    Balant L; Gorgia A; Tschopp JM; Revillard C; Fabre J
    Schweiz Med Wochenschr; 1976 Oct; 106(41):1403-7. PubMed ID: 12563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man.
    Giudicelli JF; Chauvin M; Thuillez C; Richer C; Bianchetti G; Gomeni R; Morselli PL
    Br J Clin Pharmacol; 1980 Jul; 10(1):41-9. PubMed ID: 6104973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute effects of metoprolol on blood pressure and heart rate. Value of the nitroglycerin test].
    Chaignon M; Lucsko M; Aubert P; Guédon J
    Arch Mal Coeur Vaiss; 1982 Sep; 75(9):963-9. PubMed ID: 6128964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The cardiovascular effects of the optical isomers of 1-(0-methoxy-phenoxy-)-3-isopropylamino-2-propanolo-hydrochloride (moprolol)].
    Merlo L; Brusoni B; Mussini E; Ghirardi P
    Boll Soc Ital Cardiol; 1980; 25(8):955-61. PubMed ID: 6116496
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemoenzymatic Route for the Synthesis of (S)-Moprolol, a Potential β-Blocker.
    Ghosh S; Bhaumik J; Banoth L; Banesh S; Banerjee UC
    Chirality; 2016 Apr; 28(4):313-8. PubMed ID: 26821612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics.
    Kirchheiner J; Heesch C; Bauer S; Meisel C; Seringer A; Goldammer M; Tzvetkov M; Meineke I; Roots I; Brockmöller J
    Clin Pharmacol Ther; 2004 Oct; 76(4):302-12. PubMed ID: 15470329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of atenolol and its clinical consequences in patients with angina pectoris.
    van der Vijgh WJ; Majid PA; de Feyter PJ; Wardeh R; van der Wall EE
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):375-7. PubMed ID: 7005122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of reboxetine in healthy male volunteers.
    Denolle T; Pellizzoni C; Jannuzzo MG; Poggesi I
    Clin Pharmacol Ther; 1999 Sep; 66(3):282-7. PubMed ID: 10511064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder.
    Boellner SW; Pennick M; Fiske K; Lyne A; Shojaei A
    Pharmacotherapy; 2007 Sep; 27(9):1253-62. PubMed ID: 17723079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and pharmacological study of a thiophene analogue of moprolol and related compounds.
    el-Ashmawy MB; Lissavetzky J; Darias V; Martín-Herrera D
    Arch Pharm (Weinheim); 1991 Jan; 324(1):45-8. PubMed ID: 1675047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
    Yonga GO; Oyuga HW; Njeru EK
    East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical pharmacology of trimepranol (pharmacokinetic informations and effects on heart rate in healthy individuals)].
    Mayer O; Petrlík M; Vitous J; Cepelák V
    Vnitr Lek; 1976 Nov; 22(11):1102-9. PubMed ID: 12612
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteers.
    Bareggi SR; Gambaro V; Valenti M; Benvenuti C
    Arzneimittelforschung; 1998 Jul; 48(7):730-3. PubMed ID: 9706373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of single and multiple doses of flusoxolol (Ro 31-1411) in healthy subjects.
    Gillies HC; Rogers HJ; Francis RJ; Galloway DB; Humphreys JE
    Eur J Clin Pharmacol; 1986; 31(1):113-5. PubMed ID: 2877883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.